DK163639C - Synergistisk farmaceutisk blanding af vaevsplasminogenaktivator og et prostaglandin, farmaceutisk praeparat indeholdende blandingen samt anvendelse af blandingen til fremstilling af et laegemiddel mod blodpropper - Google Patents

Synergistisk farmaceutisk blanding af vaevsplasminogenaktivator og et prostaglandin, farmaceutisk praeparat indeholdende blandingen samt anvendelse af blandingen til fremstilling af et laegemiddel mod blodpropper

Info

Publication number
DK163639C
DK163639C DK405887A DK405887A DK163639C DK 163639 C DK163639 C DK 163639C DK 405887 A DK405887 A DK 405887A DK 405887 A DK405887 A DK 405887A DK 163639 C DK163639 C DK 163639C
Authority
DK
Denmark
Prior art keywords
mixture
pharmaceutical
preparation
prostaglandin
plasminogen activator
Prior art date
Application number
DK405887A
Other languages
English (en)
Other versions
DK405887A (da
DK405887D0 (da
DK163639B (da
Inventor
Brendan Joseph Richard Whittle
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10602253&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK163639(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of DK405887D0 publication Critical patent/DK405887D0/da
Publication of DK405887A publication Critical patent/DK405887A/da
Publication of DK163639B publication Critical patent/DK163639B/da
Application granted granted Critical
Publication of DK163639C publication Critical patent/DK163639C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK405887A 1986-08-05 1987-08-04 Synergistisk farmaceutisk blanding af vaevsplasminogenaktivator og et prostaglandin, farmaceutisk praeparat indeholdende blandingen samt anvendelse af blandingen til fremstilling af et laegemiddel mod blodpropper DK163639C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868619098A GB8619098D0 (en) 1986-08-05 1986-08-05 Combination
GB8619098 1986-08-05

Publications (4)

Publication Number Publication Date
DK405887D0 DK405887D0 (da) 1987-08-04
DK405887A DK405887A (da) 1988-02-06
DK163639B DK163639B (da) 1992-03-23
DK163639C true DK163639C (da) 1992-08-17

Family

ID=10602253

Family Applications (1)

Application Number Title Priority Date Filing Date
DK405887A DK163639C (da) 1986-08-05 1987-08-04 Synergistisk farmaceutisk blanding af vaevsplasminogenaktivator og et prostaglandin, farmaceutisk praeparat indeholdende blandingen samt anvendelse af blandingen til fremstilling af et laegemiddel mod blodpropper

Country Status (10)

Country Link
US (1) US4839169A (da)
EP (1) EP0257859B1 (da)
JP (1) JPS63115823A (da)
AU (1) AU589283B2 (da)
CA (1) CA1297010C (da)
DE (1) DE3773805D1 (da)
DK (1) DK163639C (da)
GB (1) GB8619098D0 (da)
NZ (1) NZ221328A (da)
ZA (1) ZA875755B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3544663A1 (de) * 1985-12-13 1987-06-19 Schering Ag Thrombosebehandlung mit fibrinolytika und prostacyclinen
EP0299376A3 (en) * 1987-07-13 1990-01-24 William Elson Shell Prostanoid compositions and methods for reducing blood vessel dysfunction
US5270198A (en) * 1988-05-20 1993-12-14 Genentech, Inc. DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells
US5342616A (en) * 1988-06-20 1994-08-30 The Wellcome Foundation Limited Method of administering tissue plasminogen activator
US5262170A (en) * 1988-09-02 1993-11-16 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells
US5714145A (en) * 1988-09-02 1998-02-03 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US5591446A (en) * 1989-04-04 1997-01-07 Beiersdorf, A.G. Methods and agents for the prophylaxis of atopy
WO1992011866A1 (en) * 1991-01-14 1992-07-23 Duke University LAMININ SEQUENCE AS tPA ACTIVATOR
PT786257E (pt) * 1992-06-03 2003-12-31 Genentech Inc Variantes de glicosilacao do activador de plasminogenio tissular com propriedades terapeuticas meloradas

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4158667A (en) * 1976-02-04 1979-06-19 The Upjohn Company 6-Keto PGF analogs
CA1097239A (en) * 1976-05-11 1981-03-10 Salvador Moncada Enzymatic preparation of prostacyclin and its salts
FR2469411A1 (fr) * 1979-11-15 1981-05-22 Science Union & Cie Nouveaux derives de la piperidylbenzimidazolinone, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
EP0112122B1 (en) * 1982-12-14 1991-08-28 South African Inventions Development Corporation Plasminogen activator
US4661469A (en) * 1984-08-08 1987-04-28 Survival Technology, Inc. t-PA composition capable of being absorbed into the blood stream and method of administration
US4632919A (en) * 1984-09-27 1986-12-30 University Of Medicine & Dentistry Of N.J. Process for prolonging recalcification, prothrombin and thrombin times of plasma
EP0201153A3 (en) * 1985-02-09 1987-10-07 Beecham Group Plc Modified enzyme and process for its preparation
AU569429B2 (en) * 1985-05-28 1988-01-28 Wellcome Foundation Limited, The Aqueous acidic tissue plasminogen activator parenternal formulation
US4929444A (en) * 1985-05-28 1990-05-29 Burroughs Wellcome Co. Low pH pharmaceutical formulation containing t-PA
DE3544663A1 (de) * 1985-12-13 1987-06-19 Schering Ag Thrombosebehandlung mit fibrinolytika und prostacyclinen

Also Published As

Publication number Publication date
DK405887A (da) 1988-02-06
EP0257859A3 (en) 1989-07-26
DK405887D0 (da) 1987-08-04
AU7657287A (en) 1988-02-11
CA1297010C (en) 1992-03-10
DK163639B (da) 1992-03-23
GB8619098D0 (en) 1986-09-17
JPS63115823A (ja) 1988-05-20
EP0257859A2 (en) 1988-03-02
JPH0460586B2 (da) 1992-09-28
NZ221328A (en) 1990-09-26
DE3773805D1 (de) 1991-11-21
US4839169A (en) 1989-06-13
EP0257859B1 (en) 1991-10-16
ZA875755B (en) 1989-03-29
AU589283B2 (en) 1989-10-05

Similar Documents

Publication Publication Date Title
NO171344C (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende vevsplasminogenaktivator
NO862096L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende vevsplasminogenaktivator.
IT8767214A0 (it) Siringa dentaria per iniezioni intralegamentarie
DK333788A (da) Farmaceutisk praeparat til behandling af oedelagt bruskvaev
DK407588D0 (da) Oxadiazolforbindelse, farmaceutisk praeparat indeholdende en saadan forbindelse, anvendelse af forbindelsen til fremstilling af et laegemiddel samt fremgangsmaade til fremstilling af en saadan forbindelse
DK352686A (da) Steril, farmaceutisk tpa-doseringsenhed og fremgangsmaade til fremstilling deraf, beholdersaet indeholdende tpa og doseringsenhedens anvendelse
IT1233374B (it) Siringa monouso per iniezioni percutanee
DK165199C (da) Aktivatorpraeparat, fremgangsmaade til kvantitativ bestemmelse af protein c under anvendelse af praeparatet, antithrombotisk laegemiddel indeholdende praeparatet og fremgangsmaade til udvinding af aktiveret protein c under anvendelse af praeparatet
NO894999D0 (no) Antiseptiske blandinger inneholdende heksahydro-5-pyrimidinaminforbindelser og thymol og fremgangsmaater for fremstilling derav.
KR890700370A (ko) 의료용 피하 주사기
DK163639C (da) Synergistisk farmaceutisk blanding af vaevsplasminogenaktivator og et prostaglandin, farmaceutisk praeparat indeholdende blandingen samt anvendelse af blandingen til fremstilling af et laegemiddel mod blodpropper
DE3361609D1 (en) New n-((2-oxo-1-pyrrolidinyl)acetyl)piperazines, the methods of producing such new compounds and their salts as well as pharmaceutical preparations for therapeutic use containing these compounds or salts
DK226488A (da) Anvendelse af ace-inhibitorer til fremstilling af farmaceutiske praeparater
DK635988A (da) 1,3-butandiolacetoacetat-derivater og anvendelse af 1,3-butandiolacetoacetat-forbindelser til fremstilling af farmaceutiske praeparater
NO863460D0 (no) Fremgangsmaate til fremstilling av 6-fenoksymetyl-4-hydroksy-tetrahydropyran-2-on, fremgangsmaate til deres fremstilling, og deres anvendelse som legemiddel, farmasoeytiske preparater og mellomprodukter.
DK284688A (da) Beta-lactam-forbindelser, deres fremstilling og anvendelse som laegemidler
DK400887A (da) Anvendelse af 15-deoxyspergualin til fremstilling af et laegemiddel
DK424987A (da) Farmaceutisk praeparat til indgivelse gennem huden og fremgangsmaade til dets fremstilling
DK269986D0 (da) Fremgangsmaade til foroegelse af den transdermale afgivelse af laegemidler samt praeparat til transdermal administrering
DK120789D0 (da) 4-pentafluorphenoxupiperidiner, en fremgangsmaade til deres fremstilling og anvendelse af disse som laegemiddel
DK213988D0 (da) Dihydropyridinforbindelser samt medisinsk anvendelse af disse og beslaegtede forbindelser og farmaceutiske praeparater indholdende disse.
DK159434C (da) Quinoxalinforbindelser, fremgangsmaade til deres fremstilling, en anvendelse af forbindelserne og farmaceutiske praeparater hvori forbindelserne indgaar
DK159685C (da) Imidazothienopyrimidiner, farmaceutiske praeparater indeholdende disse, en anvendelse af forbindelserne og fremgangsmaade til deres fremstilling
BR6701644U (pt) Conjunto seringa medicamento descartavel
KR890008463U (ko) 일회용 주사기의 밀봉장치

Legal Events

Date Code Title Description
PBP Patent lapsed